A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab

NCT00123630 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Esophagitis

Interventions

DRUG: omalizumab
DRUG: Placebo

Sponsor

University of Utah

Collaborators

[object Object]